Abstract
Background Obesity particularly during childhood is considered a global public health crisis and has been linked with later life health consequences including mental health.However, there is lack of causal understanding if childhood adiposity has a direct effect on mental health or has an indirect effect after accounting for adulthood body size.
Objective To investigate the total and direct effect of childhood adiposity on later life anxiety and depression.
Method Two-sample Mendelian randomization (MR) was performed to estimate the total effect and direct effect (accounting for adulthood body size) of childhood body size on anxiety and depression. We used summary statistics from a genome-wide association study (GWAS) of UK Biobank (n=453,169) and large-scale consortia of anxiety (Million Veteran Program) and depression (Psychiatric Genomics Consortium) (n=175,163 and n=173,005, respectively).
Result Univariable MR did not indicate genetically predicted effects of childhood body size with later life anxiety (beta=-0.05, 95% CI=-0.13, 0.02), and depression (OR=1.06, 95% CI=0.94, 1.20). However, using multivariable MR, we observed that the higher body size in childhood reduced the risk of later life anxiety (beta=-0.19, 95% CI=-0.29, -0.08) and depression (OR=0.83, 95% CI=0.71, 0.97). Both univariable and multivariable MR indicated that higher body size in adulthood increased the risk of later life anxiety and depression.
Conclusion Our findings suggest that the higher body size in childhood has a protective effect on later life anxiety and depression, if obesity is not present into adulthood. Higher body size in adulthood was a risk factor for later life anxiety and depression.
Competing Interest Statement
The authors have declared no competing interest.
Funding Statement
This study did not receive any external funding.
Author Declarations
I confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.
Yes
The details of the IRB/oversight body that provided approval or exemption for the research described are given below:
Human genetics data used in this study are openly available for childhood and adulthood adiposity (https://rmdopen.bmj.com/content/8/2/e002321) and for depression (https://www.nature.com/articles/s41588-018-0090-3) but for anxiety data were available upon request to author (https://pubmed.ncbi.nlm.nih.gov/31906708/).
I confirm that all necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived, and that any patient/participant/sample identifiers included were not known to anyone (e.g., hospital staff, patients or participants themselves) outside the research group so cannot be used to identify individuals.
Yes
I understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).
Yes
I have followed all appropriate research reporting guidelines, such as any relevant EQUATOR Network research reporting checklist(s) and other pertinent material, if applicable.
Yes
Data Availability
1) Summary statistic for childhood and adulthood adiposity are available online. 2) Summary statistic for depression are available online. 3) Summary statistic for anxiety are available uopn request to the author through db GaP.
https://rmdopen.bmj.com/content/8/2/e002321
